trending Market Intelligence /marketintelligence/en/news-insights/trending/kIlfRRlfmxy2qXFOLT6Xrw2 content esgSubNav
In This List

German court dismisses Novartis appeal against Luye Pharma

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


German court dismisses Novartis appeal against Luye Pharma

The Court of Appeal for the district of Munich in Germany dismissed Novartis AG's appeal in a patent infringement lawsuit against Luye Pharma Group Ltd.'s Rivastigmine 1 day patch, a treatment for Alzheimer's disease.

Novartis also reimbursed the company of relevant legal expenses.